Oramed Pharmaceuticals Inc (ORMP)
2.33
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.33
0.00 (0.00%)
After-Hours: 18:45
Oramed Pharmaceuticals Price to Book Value: 0.5365 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.5353 |
| November 12, 2024 | 0.5388 |
| November 11, 2024 | 0.5342 |
| November 08, 2024 | 0.5319 |
| November 07, 2024 | 0.548 |
| November 06, 2024 | 0.5388 |
| November 05, 2024 | 0.5411 |
| November 04, 2024 | 0.5503 |
| November 01, 2024 | 0.5342 |
| October 31, 2024 | 0.548 |
| October 30, 2024 | 0.5549 |
| October 29, 2024 | 0.5273 |
| October 28, 2024 | 0.5342 |
| October 25, 2024 | 0.5445 |
| October 24, 2024 | 0.5434 |
| October 23, 2024 | 0.548 |
| October 22, 2024 | 0.5457 |
| October 21, 2024 | 0.5399 |
| October 18, 2024 | 0.533 |
| October 17, 2024 | 0.5526 |
| October 16, 2024 | 0.5595 |
| October 15, 2024 | 0.5411 |
| October 14, 2024 | 0.548 |
| October 11, 2024 | 0.548 |
| October 10, 2024 | 0.5468 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.5526 |
| October 08, 2024 | 0.5365 |
| October 07, 2024 | 0.5549 |
| October 04, 2024 | 0.5411 |
| October 03, 2024 | 0.5549 |
| October 02, 2024 | 0.5503 |
| October 01, 2024 | 0.5526 |
| September 30, 2024 | 0.5618 |
| September 27, 2024 | 0.571 |
| September 26, 2024 | 0.5526 |
| September 25, 2024 | 0.5503 |
| September 24, 2024 | 0.5411 |
| September 23, 2024 | 0.5353 |
| September 20, 2024 | 0.5319 |
| September 19, 2024 | 0.5687 |
| September 18, 2024 | 0.5572 |
| September 17, 2024 | 0.5779 |
| September 16, 2024 | 0.571 |
| September 13, 2024 | 0.5733 |
| September 12, 2024 | 0.5434 |
| September 11, 2024 | 0.548 |
| September 10, 2024 | 0.5526 |
| September 09, 2024 | 0.5549 |
| September 06, 2024 | 0.5411 |
| September 05, 2024 | 0.5319 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4619
Minimum
Nov 01 2023
11.80
Maximum
Feb 17 2021
2.732
Average
2.006
Median
Jan 21 2022
Price to Book Value Benchmarks
| Skye Bioscience Inc | 2.304 |
| Scilex Holding Co | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.8831 |
Price to Book Value Related Metrics
| PE Ratio | 4.569 |
| PS Ratio | 35.59 |
| Price | 2.33 |
| Earnings Yield | 21.89% |
| Market Cap | 94.99M |